« Back to Record
Citation APA

Garg, A. A., Vandenberk, L., Van Woensel, M., Belmans, J., Schaaf, M., Boon, L., De Vleeschouwer, S., & Agostinis, P. M. (2017). Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma. Oncoimmunology, 6(4), e1295903. doi:10.1080/2162402X.2017.1295903


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253230

Garg, A. A., Vandenberk, L., Van Woensel, M., Belmans, J., Schaaf, M., Boon, L., De Vleeschouwer, S., & Agostinis, P. M. (2017). Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma. Oncoimmunology, 6(4), e1295903. doi:10.1080/2162402X.2017.1295903